Zobrazeno 1 - 10
of 244
pro vyhledávání: '"Zanelli, U."'
Publikováno v:
Frontiers in Psychiatry, Vol 5 (2014)
Externí odkaz:
https://doaj.org/article/5e57a3e7a8f04034b4dcd9fa600e96d0
Autor:
Crosignani S; Galderma SA, Av. d'Ouchy 4, 1006 Lausanne, Switzerland. Electronic address: stefano.crosignani@gmail.com., Campos S; Pharmaron Discovery & Early Development, West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, UK., Bouix-Peter C; Galderma SA, Av. d'Ouchy 4, 1006 Lausanne, Switzerland., Harris C; Galderma SA, Av. d'Ouchy 4, 1006 Lausanne, Switzerland., Talbot E; Pharmaron Discovery & Early Development, West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, UK., Hu H; Pharmaron Discovery & Early Development, West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, UK., Wang S; Pharmaron Discovery & Early Development, West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, UK., Maclean J; Pharmaron Discovery & Early Development, West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, UK., Zanelli U; Galderma SA, Av. d'Ouchy 4, 1006 Lausanne, Switzerland., Taylor S; Pharmaron Discovery & Early Development, West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, UK., Foote K; Pharmaron Discovery & Early Development, West Hill Innovation Park, Hertford Road, Hoddesdon, Hertfordshire EN11 9FH, UK., Hacini-Rachinel F; Galderma SA, Av. d'Ouchy 4, 1006 Lausanne, Switzerland., Nicodeme E; Galderma SA, Av. d'Ouchy 4, 1006 Lausanne, Switzerland., Julia V; Galderma SA, Av. d'Ouchy 4, 1006 Lausanne, Switzerland.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2024 Mar 01; Vol. 100, pp. 129630. Date of Electronic Publication: 2024 Feb 01.
Autor:
Billié S; Galderma SA, Av. d'Ouchy 4, Lausanne 1006, Switzerland., Reversé K; Nuvisan France SARL - CS 10287, Sophia-Antipolis 06905, France., Arlabosse JM; Nuvisan France SARL - CS 10287, Sophia-Antipolis 06905, France., Bertin D; Galderma SA, Av. d'Ouchy 4, Lausanne 1006, Switzerland., Boulier A; Laboratoires Galderma SAS, ZI Montdésir, Alby-sur-Chéran 74540, France., Cachot T; Nuvisan France SARL - CS 10287, Sophia-Antipolis 06905, France., Chambon S; Nuvisan France SARL - CS 10287, Sophia-Antipolis 06905, France., Charras K; Laboratoires Galderma SAS, ZI Montdésir, Alby-sur-Chéran 74540, France. Electronic address: karine.charras@galderma.com., Cren C; Galderma SA, Av. d'Ouchy 4, Lausanne 1006, Switzerland., Furnes B; Galderma SA, Av. d'Ouchy 4, Lausanne 1006, Switzerland., Gerfaud T; Nuvisan France SARL - CS 10287, Sophia-Antipolis 06905, France., Joly-Battaglini M; Galderma SA, Av. d'Ouchy 4, Lausanne 1006, Switzerland., Longoni D; Olon SpA, Strada Rivoltana, km 6/7, Rodano, Milan 20053, Italy., Mouis G; Nuvisan France SARL - CS 10287, Sophia-Antipolis 06905, France., Pierre R; Nuvisan France SARL - CS 10287, Sophia-Antipolis 06905, France., Raynard H; Galderma SA, Av. d'Ouchy 4, Lausanne 1006, Switzerland., Texier T; Nuvisan France SARL - CS 10287, Sophia-Antipolis 06905, France., Trognon C; Galderma SA, Av. d'Ouchy 4, Lausanne 1006, Switzerland., Zanelli U; Galderma SA, Av. d'Ouchy 4, Lausanne 1006, Switzerland., Boiteau JG; Nuvisan France SARL - CS 10287, Sophia-Antipolis 06905, France. Electronic address: Jean-Guy.Boiteau@nuvisan.com., Harris CS; Galderma SA, Av. d'Ouchy 4, Lausanne 1006, Switzerland. Electronic address: craigstevenharris@gmail.com.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2023 Sep 01; Vol. 188, pp. 106519. Date of Electronic Publication: 2023 Jul 19.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Toxicology in Vitro 2000 14(1):69-77
Autor:
Sanderson MP; Merck KGaA, Darmstadt, Germany. michael.sanderson@merckgroup.com., Friese-Hamim M; Merck KGaA, Darmstadt, Germany., Walter-Bausch G; Merck KGaA, Darmstadt, Germany., Busch M; Merck KGaA, Darmstadt, Germany., Gaus S; Merck KGaA, Darmstadt, Germany., Musil D; Merck KGaA, Darmstadt, Germany., Rohdich F; Merck KGaA, Darmstadt, Germany., Zanelli U; Merck KGaA, Darmstadt, Germany., Downey-Kopyscinski SL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schadt O; Merck KGaA, Darmstadt, Germany., Klein M; Merck KGaA, Darmstadt, Germany., Esdar C; Merck KGaA, Darmstadt, Germany.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2021 Aug; Vol. 20 (8), pp. 1378-1387. Date of Electronic Publication: 2021 May 27.
Autor:
Klein M; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Busch M; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Friese-Hamim M; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Crosignani S; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Fuchss T; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Musil D; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Rohdich F; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Sanderson MP; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Seenisamy J; Syngene International Limited, Biocon Park, Plot2&3, Bommasandra-Jigani Link Road, Bangalore 560 099, India., Walter-Bausch G; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Zanelli U; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Hewitt P; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Esdar C; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany., Schadt O; Merck KGaA, Frankfurter Str. 250, Darmstadt 64293, Germany.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2021 Jul 22; Vol. 64 (14), pp. 10230-10245. Date of Electronic Publication: 2021 Jul 06.
Autor:
Zanelli U; a Global Early Development/Quantitative Pharmacology and Drug Disposition (QPD) , Biopharma, Merck , Darmstadt , Germany., Michna T; a Global Early Development/Quantitative Pharmacology and Drug Disposition (QPD) , Biopharma, Merck , Darmstadt , Germany., Petersson C; a Global Early Development/Quantitative Pharmacology and Drug Disposition (QPD) , Biopharma, Merck , Darmstadt , Germany.
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems [Xenobiotica] 2019 Apr; Vol. 49 (4), pp. 381-387. Date of Electronic Publication: 2018 Mar 26.
Autor:
Gouliarmou V; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy., Lostia AM; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy., Coecke S; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy. Electronic address: sandra.coecke@ec.europa.eu., Bernasconi C; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy., Bessems J; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy., Dorne JL; European Food Safety Authority, Via Carlo Magno, 1A, 43126 Parma, PR, Italy., Ferguson S; US National Toxicology Program, National Institute of Environmental Health Sciences, Durham, NC 27709, USA., Testai E; Istituto Superiore di Sanità, Environment & Health Dept., Viale Regina Elena 299, 00161 Rome, Italy., Remy UG; Institute for Clinical Pharmacology and Toxicology, Charité, Universitätsmedizin Berlin, Charitéplatz 1, D-110117 Berlin, Germany., Brian Houston J; Manchester Pharmacy School, University of Manchester, Manchester M13 9PT, UK., Monshouwer M; Janssen Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium., Nong A; Computational Toxicology Laboratory, Exposure and Biomonitoring Division, Health Canada - Environmental Health Science and Research Bureau, 50 Colombine Dwy, Environmental Health Centre, Tunney's Pasture AL:0800C, Ottawa, ON K1A 0K9, Canada., Pelkonen O; Research Unit of Biomedicine/Pharmacology and Toxicology, Faculty of Medicine, Aapistie 5 B, FIN-90014, University of Oulu, Finland., Morath S; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy., Wetmore BA; U.S. EPA, Office of Research and Development, National Exposure Research Laboratory, 109 T.W. Alexander Drive, MD E243-04, Research Triangle Park, NC 27711, USA., Worth A; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy., Zanelli U; Discovery DMPK, Merck KGaA Darmstadt, Germany., Zorzoli MC; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy., Whelan M; European Commission, Joint Research Centre (JRC), Via Enrico Fermi 2749, 21027 Ispra, VA, Italy.
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA [Toxicol In Vitro] 2018 Dec; Vol. 53, pp. 233-244. Date of Electronic Publication: 2018 Aug 09.
The production of the carrot phytoalexin, 6-methoxymellein, and its immediate biosynthetic precursor, 6-hydroxymellein, was induced in suspension cultures by biotic elicitors (Aspergillus niger pectinase and purified endo-polygalacturonase from Fusar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6854d9a6b5b0e145d66059dccc41d641
http://hdl.handle.net/11383/1789959
http://hdl.handle.net/11383/1789959